| Bioactivity | Cbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 µM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation[1]. |
| Target | IC50: Cbl-b (3-10 µM). |
| Name | Cbl-b-IN-5 |
| CAS | 2368835-59-8 |
| Formula | C17H17N5OS |
| Molar Mass | 339.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1. |